Bright Minds BiosciencesDRUG
13F holders, Q1 2024 (March 31)7holders
1famous investor
$1.20avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Bright Minds Biosciences Inc. (DRUG) in their 13F filings. The largest holders were AdvisorShares Investments LLC ($211K), Citadel Advisors ($21K) and Jane Street Group, LLC ($17K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Bright Minds Biosciences Inc.
- CUSIP
- 10919W405
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $43K |
| Exits | 4 | $57K |
Ownership 7 holders
| AdvisorShares Investments LLC | 0.04% | Reduce -6.4% | 176,038 | $211K |
| Citadel Advisors | 0.00% | New | 17,829 | $21K |
| Jane Street Group, LLC | 0.00% | New | 13,795 | $17K |
| National Bank of Canada | 0.00% | New | 5,000 | $5K |
| Royal Bank of Canada | 0.00% | Add +120.1% | 612 | $1K |
| Aspire Private Capital, LLC | 0.00% | No change | 100 | $120 |
| BlackRock Inc. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is DRUG's weight in each manager's 13F, not the share of Bright Minds Biosciences Inc. the manager owns.